Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to -$27000.0.

  • Utah Medical Products' Cash from Investing Activities rose 6966.29% to -$27000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$271000.0, marking a year-over-year increase of 622.84%. This contributed to the annual value of -$208000.0 for FY2024, which is 6744.91% up from last year.
  • Utah Medical Products' Cash from Investing Activities amounted to -$27000.0 in Q3 2025, which was up 6966.29% from -$51000.0 recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Cash from Investing Activities ranged from a high of $5000.0 in Q1 2024 and a low of -$321000.0 during Q3 2022
  • For the 5-year period, Utah Medical Products' Cash from Investing Activities averaged around -$130473.7, with its median value being -$90000.0 (2023).
  • Per our database at Business Quant, Utah Medical Products' Cash from Investing Activities soared by 11162.79% in 2024 and then crashed by 378000.0% in 2025.
  • Utah Medical Products' Cash from Investing Activities (Quarter) stood at -$253000.0 in 2021, then skyrocketed by 84.98% to -$38000.0 in 2022, then tumbled by 136.84% to -$90000.0 in 2023, then skyrocketed by 90.0% to -$9000.0 in 2024, then crashed by 200.0% to -$27000.0 in 2025.
  • Its last three reported values are -$27000.0 in Q3 2025, -$51000.0 for Q2 2025, and -$184000.0 during Q1 2025.